Ohio State biotech spinoff targeting MD raises $182M in IPO

Entrada Logo

Ohio State University has a stake in a record-breaking year for IPOs: A spinoff just raised more in its debut than any other company licensing university technology.

Entrada Therapeutics Inc. raised $181.5 million before expenses in its offering just over a week ago, which sister publication Boston Business Journal dubbed one of the largest biotech IPOs to date this year. The Boston-based company sold 9.1 million shares at $19 each, the midpoint of its range, then rose about 20% in its first few hours of trading.

Click here to read the complete story.

Story excerpt provided by Columbus Inno.

Written by Carrie Ghose.

Originally published November 9, 2021.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: